Skip to content
Medxy AI
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • Alcon
Alcon’s Tryptyr: A New Neuromodulatory Approach for Rapid Dry Eye Relief
Posted inClinical Updates Wellness & Lifestyle

Alcon’s Tryptyr: A New Neuromodulatory Approach for Rapid Dry Eye Relief

Posted by By MedXY 08/02/2025
Alcon introduces Tryptyr, the first TRPM8 agonist eye drop, promising rapid tear production for dry eye disease. FDA-approved in May 2024 following robust phase 3 trials.
Read More
  • How Should Diabetic Patients Consume Fruits?
  • 30 Practical Tips for Effective and Healthy Weight Loss
  • Can Merely Seeing Infection Activate Real Immunity? The Neuroscience of Virtual Pathogens and Immunological Anticipation
  • One Exercise Session Can Fight Cancer! Latest Study Confirms: These Two Exercise Types Instantly Produce Anti-Cancer Substances That Significantly Inhibit Cancer Cell Growth
  • The Science of Sleep: Optimal Bedtime and Its Impact on Health
  • About us
  • Contact us
  • Privacy Policy
  • Subscribe Now!
  • English
  • 日本語
  • Tiếng Việt
  • 中文

aging Alzheimer's disease Antibiotics breast cancer cardiovascular health clinical trial clinical trials Dementia diabetes diet epidemiology exercise FDA FDA approval gut health health healthcare HIV Hypertension immunotherapy longevity maternal health men's health mental health multiple myeloma nutrition obesity older adults Pediatrics Pregnancy prevention public health randomized trial semaglutide sexual health sleep stroke targeted therapy treatment type 2 diabetes vaccination Vaccine weight loss wellness women's health

Your health, we care

Copyright 2025 — Medxy AI. All rights reserved.
Scroll to Top